A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E. Rinella, Zobair M. Younossi, Jeffrey V. Lazarus et al.|Hepatology|2023Cited by 2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E. Rinella, Zobair M. Younossi, Fasiha Kanwal et al.|Journal of Hepatology|2023Cited by 2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)Frank Tacke, Dror Dicker, Paul Horn et al.|Journal of Hepatology|2024Cited by 1.6k
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E. Rinella, Zobair M. Younossi, Jeffrey V. Lazarus et al.|Annals of Hepatology|2023Cited by 789
The global burden of metabolic disease: Data from 2000 to 2019Nicholas Chew, Mark Muthiah, Cheng Han Ng et al.|Cell Metabolism|2023Cited by 777